I'm Coming Out: the Stigma Around GLP-1s, and the Role of Data in Health Choices
Weight loss has been a journey for me—a long and, at times, exhausting one. Like many others, I’ve worked hard through “traditional” methods, losing over 100 pounds twice in my adult life. But while I could lose the weight, keeping it off was a different story. Weight loss required intense, almost obsessive dedication, taking over my thoughts and daily routines. Both times it was accompanied by huge numbers of hours in the gym. A little over 3 weeks ago: I began taking ZepBound, a GLP-1 receptor agonist designed to aid in weight loss.
For years, I’ve been aware of ZepBound, weighing its potential benefits and risks and the fact that I just needed to make the decision to lose weight again and I didn’t need a drug. Well, no matter how many times I started that diet I’d get derailed. I finally decided it was worth a try, and for me that required I pay $65 to an online provider to onboard, another $25 for them to call in a prescription, and $550 a month because I qualified for the discount code. BEFORE I even know if this will work, I'm in it for the price of a new upgraded m4 Mac Mini.
This isn’t a small financial commitment, and there are people paying $1200 for just the drug every 4 weeks because they don’t qualify.
Thank God, after spending that much within days, my relationship with food transformed. I quickly realized that choosing this path came with unexpected judgments from others. Many people still view GLP-1 medications as “cheating” or taking the “easy way out.” This stigma around weight loss medications is a real barrier to open discussion and acceptance, even though medications like ZepBound have been food relationship changing for people like me.
In sharing my experience, I want to break down some of these stigmas and illustrate how data and biomedical informatics can help people make informed, personalized health decisions.
How ZepBound Changed My Life and My Relationship with Food
On the second day of taking ZepBound, I felt a shift that surprised me. I went from eating around 4,500 calories daily to closer to 1,500 or 2,000, without trying to diet. For the first time in years, I found myself not finishing my meals, almost as if my brain was rewiring its relationship with food. This wasn’t about sheer willpower; something fundamental had changed. My constant thoughts about food, a phenomenon many people on GLP-1s call “food noise,” began to quiet.
That “food noise” had always been part of my daily life, dictating my thoughts, my cravings, and often my plans. On ZepBound, I walk out the door without snacks or walk past the fridge without a second thought. For the first time in my life I understood why the serving size was set at its benchmark, I’ve never even at my lightest found myself sated by a serving size until now. The freedom this gave me is invaluable, its a stressful time of my life and I’m not overeating!
The Stigmas Surrounding GLP-1 Weight Loss Medications
As incredible as this shift was for me, I soon learned that there’s a stigma around using weight loss medications like ZepBound. People don’t want to say they are using it. Here’s a closer look at the misconceptions and biases that people face and why we need to rethink them:
Even I’ve been contemplating the reality of whether I want to admit anything because it may impact my job search negatively.
Recommended by LinkedIn
What can we biomedical informaticians do about this all?
A small silly example, Recent research suggests that Zepbound can enhance sleep quality and eliminate sleep apnea. An example of data we don’t collect routinely as a health system are sleep apnea machine’s nightly data, I happen to use a CPAP machine to manage sleep apnea and I’m interested in using my own data to see how my sleep evolves over time. A microcosm of 1 that we should be evaluating in more systems.
Biomedical informatics gives us the power to analyze this kind of data ourselves, allowing us to make informed decisions and observe trends that might otherwise go unnoticed. By looking at things like sleep duration, the frequency of interruptions, and oxygen levels, I can directly see whether this intervention is benefiting me.
The Role of Biomedical Informatics in Real-World Decision-Making
Biomedical informaticians have a unique role in helping people make data-driven health decisions. Here are some ways that informatics can contribute to more informed choices, particularly when it comes to GLP-1s and other new treatments:
Ending the Stigma Around GLP-1s and Embracing a Data-Driven Health Approach
My decision to take ZepBound was not about taking the “easy way out.” It was about finding a solution that gave me the freedom I’d been searching for. You can't see dramatic weight loss, I’m early in my journey, I didn’t believe the first weeks were more than psychosomatic, and heck while it still could be, I’m feeling great about it and think this is going to help me get to my goals. If you aren't over a 30 BMI don't use the drugs, its got risk profiles we should talk about if you are thinking about it. We'll find safer alternatives in the upcoming years.
Reducing the stigma around weight loss medications like ZepBound means approaching health as a spectrum with multiple paths, not a single “right” way. Each person’s health journey is unique, and the support of data-driven insights can empower us to make the best decisions for our own lives. Through better understanding and open conversations, we can foster a culture that respects all health journeys and the tools we use along the way.
Clinical and Research Informatics Leader | OMOP | Knowledge Management Systems (KMS) | Data Architecture | RWE/RWD | Focused on making healthcare data ready for clinical research
3moJeremy Harper thank you for the excellent article and considered perspective on this topic. It is truly multifaceted and congrats on finding success. It can’t be easy, especially with the stress/workload of your new book! Hope I’ll still recognize ya at any upcoming OHDSI or AMIA Conference 😁